
|Articles|July 30, 2002
Drug Fee Act appears to be achieving its goals
Washington, D.C. - The Prescription Drug User Fee Act of 1992 reducedthe time the U.S. Food and Drug Administration needs to review and approvenew pharmaceuticals, said the Tufts Center for the Study of Drug Development.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
3
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
4
Off-Label Case Series: Topical Roflumilast for Mild HS
5


















